Endocrinology at Huashan Hospital Shanghai | CMCS

Expert Hormonal & Metabolic Care at One of China's Premier Academic Medical Centers

The Department of Endocrinology at Huashan Hospital — affiliated with Fudan University — is one of China's most distinguished endocrinology centers, with a particular national reputation for excellence in pituitary and adrenal disorders, thyroid disease, neuroendocrine tumors, and the management of complex hormonal conditions. The department combines outstanding clinical expertise with a productive research program, offering international patients access to some of China's most eminent endocrinologists and the latest evidence-based treatments for difficult hormonal and metabolic conditions.

For international patients seeking expert endocrinology care in Shanghai — whether for a pituitary tumor, Cushing's syndrome, primary aldosteronism, a rare adrenal condition, or a complex thyroid disorder — Huashan Hospital's endocrinology department represents one of the most compelling destinations in Asia, particularly for neuroendocrine and pituitary conditions given its close integration with Huashan's world-renowned neurosurgery department. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their care journey.

About the Department

Huashan Hospital's endocrinology department is a national key clinical specialty operating a comprehensive endocrine unit with dedicated inpatient wards, subspecialty clinics for pituitary disease, adrenal disorders, thyroid disease, diabetes, and neuroendocrine tumors, a dynamic endocrine function testing suite, and a dedicated neuroendocrinology program closely integrated with the neurosurgery department's pituitary surgery program.

The department's particular strength in pituitary and adrenal disorders reflects Huashan's unique position as a leading neurosurgical center — the combination of expert endocrinological evaluation and world-class pituitary neurosurgery creates an unparalleled program for patients with pituitary adenomas, Cushing's disease, acromegaly, and other sellar and parasellar conditions. Faculty members publish regularly in leading endocrinology journals including Journal of Clinical Endocrinology & Metabolism, European Journal of Endocrinology, Endocrine-Related Cancer, and Clinical Endocrinology.

Conditions Treated

Pituitary Disorders

• Pituitary Adenoma (Non-Functioning) — Observation, surgical resection, and radiation therapy; visual field monitoring; pituitary hormone replacement
• Prolactinoma — Dopamine agonist therapy (cabergoline, bromocriptine); surgical resection for drug-resistant or intolerant cases
• Acromegaly (GH-Secreting Adenoma) — Transsphenoidal surgery; somatostatin analogues (octreotide LAR, lanreotide); pegvisomant; pasireotide for resistant disease; stereotactic radiosurgery
• Cushing's Disease (ACTH-Secreting Adenoma) — Inferior petrosal sinus sampling (IPSS) for lateralization; transsphenoidal surgery; pasireotide, osilodrostat, and metyrapone for medical management; bilateral adrenalectomy for refractory disease
• TSH-Secreting Adenoma — Transsphenoidal surgery and somatostatin analogue therapy
• Craniopharyngioma — Surgical and radiation management in collaboration with neurosurgery; pituitary hormone replacement
• Hypopituitarism — Comprehensive pituitary hormone replacement including growth hormone, cortisol, thyroid hormone, sex steroids, and ADH
• Diabetes Insipidus — Central and nephrogenic DI; desmopressin therapy; underlying cause investigation
• SIADH & Hyponatremia — Fluid restriction, tolvaptan, and urea therapy; underlying cause management

Adrenal Disorders

• Cushing's Syndrome — Comprehensive evaluation including 24-hour UFC, late-night salivary cortisol, low-dose DST, and high-dose DST; IPSS for Cushing's disease; adrenal CT and adrenal vein sampling (AVS); medical and surgical management
• Primary Aldosteronism — Aldosterone-to-renin ratio screening; confirmatory testing; adrenal vein sampling (AVS) for lateralization; adrenalectomy and mineralocorticoid antagonist therapy
• Pheochromocytoma & Paraganglioma — Biochemical diagnosis (plasma/urine metanephrines); functional imaging (MIBG, DOTATATE PET); alpha-blockade and surgical resection; SDH mutation testing
• Adrenal Incidentaloma — Systematic evaluation for hormonal excess and malignancy; surveillance protocols
• Adrenal Insufficiency — Primary (Addison's disease) and secondary; glucocorticoid and mineralocorticoid replacement; sick day rules and emergency management
• Congenital Adrenal Hyperplasia (CAH) — 21-hydroxylase deficiency and other forms; glucocorticoid optimization; fertility management
• Adrenocortical Carcinoma — Surgical resection and mitotane therapy; clinical trial access

Thyroid Disorders

• Thyroid Nodules & Cancer — Ultrasound-guided FNA; molecular testing (BRAF, RAS, RET/PTC); thyroidectomy coordination; radioiodine therapy; targeted therapy (lenvatinib, sorafenib, selpercatinib, pralsetinib) for advanced thyroid cancer
• Differentiated Thyroid Cancer — Post-surgical radioiodine ablation; TSH suppression therapy; surveillance
• Medullary Thyroid Cancer — RET mutation testing; vandetanib and cabozantinib; selpercatinib for RET-mutated MTC
• Graves' Disease & Hyperthyroidism — Antithyroid drugs, radioiodine, and thyroidectomy; Graves' ophthalmopathy management with teprotumumab
• Hashimoto's Thyroiditis & Hypothyroidism — Levothyroxine optimization; subclinical hypothyroidism management
• Thyroid Storm — Emergency management of severe thyrotoxicosis

Diabetes & Metabolic Disease

• Type 1 & Type 2 Diabetes — Comprehensive management; CGM; insulin pump therapy; GLP-1 agonists and SGLT2 inhibitors
• Diabetic Complications — Nephropathy, neuropathy, and retinopathy management
• Obesity & Metabolic Syndrome — Medical weight management with semaglutide and tirzepatide
• Hypoglycemia Disorders — Insulinoma evaluation; non-islet cell tumor hypoglycemia; post-bariatric hypoglycemia

Neuroendocrine Tumors (NETs)

• Gastroenteropancreatic NETs — Somatostatin analogue therapy (octreotide, lanreotide); PRRT (peptide receptor radionuclide therapy); everolimus and sunitinib; surgical coordination
• Carcinoid Syndrome — Somatostatin analogues and telotristat for refractory diarrhea
• MEN1 & MEN2 Syndromes — Genetic testing and surveillance; multidisciplinary management
• VIPoma, Glucagonoma & Other Functional NETs — Hormonal control and surgical coordination

Bone & Calcium Metabolism

• Primary Hyperparathyroidism — Sestamibi scan and 4D CT for localization; parathyroidectomy coordination; cinacalcet for non-surgical candidates
• Hypoparathyroidism — Calcium and active vitamin D replacement; PTH replacement therapy (natpara)
• Osteoporosis — DEXA scanning; bisphosphonates, denosumab, romosozumab, and teriparatide
• Vitamin D Deficiency & Metabolic Bone Disease — Rickets, osteomalacia, and Paget's disease

Pituitary-Neurosurgery Integration: A Unique Strength

Huashan Hospital's endocrinology department benefits from a uniquely close integration with the hospital's world-class neurosurgery department — one of China's highest-volume pituitary surgery programs. This integration creates a seamless pathway for patients with pituitary tumors:

• Endocrinological evaluation and dynamic testing to characterize pituitary hormone excess and deficiency
• Multidisciplinary pituitary tumor board review with neurosurgery, endocrinology, neuroradiology, and radiation oncology
• Endoscopic endonasal transsphenoidal surgery by experienced pituitary neurosurgeons
• Post-operative endocrinological assessment and hormone replacement optimization
• Long-term surveillance for recurrence and pituitary function

Why International Patients Choose Huashan Endocrinology

• Pituitary & Adrenal Expertise — National leadership in Cushing's syndrome, acromegaly, and primary aldosteronism with IPSS and AVS capabilities
• Neurosurgery Integration — Seamless pituitary tumor board and surgical pathway with China's top neurosurgery department
• Neuroendocrine Tumor Program — Comprehensive NET management including PRRT coordination
• Advanced Thyroid Cancer Management — Targeted therapy for RAI-refractory and advanced thyroid cancers
• Rare Endocrine Disease Expertise — CAH, adrenocortical carcinoma, MEN syndromes, and other rare conditions
• Cost-Effectiveness — World-class endocrinology care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your endocrine history, recent blood tests, dynamic function test results, imaging, and current medications with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate endocrinologist based on your condition — pituitary, adrenal, thyroid, diabetes, or neuroendocrine tumor.
4. Priority Scheduling — We secure a consultation with minimal waiting time.
5. Travel & Logistics — Assistance with visa invitation letters, accommodation near Huashan Hospital, and Shanghai airport transfers.
6. On-Site Concierge — Bilingual coordinators accompany you throughout your hospital visits, managing registration, translation, and communication.
7. Diagnostic Support — Full coordination of dynamic endocrine function tests, imaging, IPSS, AVS, and other required investigations.
8. Post-Consultation Follow-Up — Test result translation, treatment plan interpretation, and remote follow-up coordination after you return home.

Book a Consultation

If you are seeking expert endocrinology care in Shanghai — whether for a pituitary tumor, Cushing's syndrome, acromegaly, adrenal disorder, thyroid cancer, neuroendocrine tumor, or a rare hormonal condition — CMCS can arrange a specialist consultation with Huashan Hospital's endocrinology team.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com